Edition:
United States

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

11.79USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$11.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
191,373
52-wk High
$33.78
52-wk Low
$10.01

INSY.OQ

Chart for INSY.OQ

About

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $951.67
Shares Outstanding(Mil.): 71.77
Dividend: --
Yield (%): --

Financials

  INSY.OQ Industry Sector
P/E (TTM): 41.79 42.21 29.87
EPS (TTM): 0.32 -- --
ROI: 9.21 -1.09 14.95
ROE: 9.49 -2.39 16.29

BRIEF-Insys Therapeutics posts Q3 adjusted EPS $0.07

* Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Nov 03 2016

Ex-Insys employee charged with fraud scheme involving fentanyl drug

A former Insys Therapeutics Inc executive has been criminally charged for conspiring to defraud insurers into paying for a fentanyl-based cancer pain drug that was sometimes prescribed for off-label uses.

Oct 17 2016

BRIEF-Insys Therapeutics reports preliminary estimated revenues from Subsys for Q3 2016 to be $54 mln -$55 mln

* Insys Therapeutics reports preliminary estimated revenues from subsys for the third quarter 2016

Oct 13 2016

Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Sep 29 2016

Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Sep 29 2016

UPDATE 2-Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

Sept 29 A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Sep 29 2016

Ex-Insys sales manager arrested in fentanyl-kickback case -U.S. prosecutors

Sept 29 A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges that he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Sep 29 2016

BRIEF-Insys Therapeutics announces CEO succession plan

* Board has appointed a special committee, comprised of independent board members to conduct search for company's next CEO

Sep 21 2016

Illinois attorney general sues Insys over fentanyl drug marketing

Illinois' attorney general on Thursday sued Insys Therapeutics Inc, accusing it of deceptively marketing and selling an addictive fentanyl-based medication, intended to treat cancer pain, to doctors for off-label uses.

Aug 25 2016

Illinois attorney general sues Insys over fentanyl drug marketing

Illinois' attorney general on Thursday sued Insys Therapeutics Inc, accusing it of deceptively marketing and selling an addictive fentanyl-based medication, intended to treat cancer pain, to doctors for off-label uses.

Aug 25 2016

Earnings vs. Estimates